MUC5B and rheumatoid arthritis: In sex-specific analyses, the lifetime risk was 20.9% (95% CI: 14.1%–27.1%) in men with RA who are MUC5B carriers, and the corresponding lifetime risk in women was 14.5% (95% CI: 10.2%–18.6%).